Fingerprint
Dive into the research topics of 'A Phase 1B open-label study of gedatolisib (PF-05212384) in combination with other anti-tumour agents for patients with advanced solid tumours and triple-negative breast cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically